Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBbva Ord Regulatory News (BVA)

Share Price Information for Bbva Ord (BVA)

Share Price is delayed by 15 minutes
Get Live Data
19.45    -0.65 (-3.23%)
Bid:
19.00
Ask:
19.90
Spread: 0.90 (4.737%)
Market Cap: €111.86b
BVA Live PriceLast checked at - London Stock Exchange

Intraday Bbva Ord Share Chart

"Dividend Option" execution timetable

12 Sep 2014 17:53

RNS Number : 5998R
Banco Bilbao Vizcaya Argentaria SA
12 September 2014
Β 

ο»Ώ

Banco Bilbao Vizcaya Argentaria, S.A. (BBVA), in compliance with the Securities Market legislation, hereby proceeds by means of the present document to notify the following:

Β 

Β 

RELEVANT EVENTΒ 

Β 

Β 

BBVA hereby communicates relevant information relating to the free-of-charge capital increase resolved by the General Meeting of BBVA shareholders held on 14th March 2014, under agenda item four, section 4.2, by which a system of flexible shareholder remuneration called "Dividend Option" is to be instrumented. Accompanying this relevant event notice is an information note related to the Dividend Option.

Β 

Β 

Β 

Β 

Madrid, 12th September 2014

INFORMATION NOTE

Β 

Β 

Β 

The General Meeting of BBVA shareholders held on 14th March 2014, under agenda item four, section 4.2, approved a free-of-charge capital increase for the instrumentation of the system of shareholder remuneration called "Dividend Option", which permits shareholders to elect to receive their remuneration in BBVA shares or, at their election, in cash.

Β 

The execution of such free-of-charge capital increase will be proposed for consideration by BBVA's Board of Directors, so that the Dividend Option may be implemented during October.

Β 

If BBVA's Board of Directors approves the execution of such free-of-charge capital increase in the terms and conditions of the proposal, it is expected to be executed in accordance with the following timetable:

Β 

Β· 24th September 2014: Communication of the number of rights necessary to receive one new share, and the definitive price at which BBVA has committed to purchase rights.

Β 

Β· 26th September 2014 (23:59 Madrid (Spain) time): Record date for allocation of rights.

Β 

Β· 29th September 2014: Rights trading period begins in Spain.

Β· 8th October 2014: Deadline for requesting payment in cash (sale of rights to BBVA).

Β 

Β· 13th October 2014: Rights trading period ends.

Β 

Β· 16th October 2014: Payment date to shareholders who have requested payout in cash (sale of rights to BBVA).

Β 

Β· 23rd October 2014: New shares allocated to shareholders.

Β 

Β· 24th October 2014: Initiation of ordinary trading of the new shares on the Spanish exchanges, subject to obtaining all necessary authorisations.

Β 

Finally, it is estimated that, assuming BBVA's Board of Directors approves the proposal for the execution of such free-of-charge capital increase, the approximate purchase price at which BBVA will purchase rights, in accordance with the formula approved by the General Meeting of BBVA shareholders, will be around 0.08 euros per right.

Β 

Madrid, 12th September 2014

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCKMGMLVZZGDZM
Date   Source Headline
4th Jan 20227:00 amRNS220103_BBVA_Share Buyback Follow up Reporting
29th Dec 20219:34 amRNSBBVA_ Shares Buyback_Follow up Reporting
29th Dec 20217:00 amRNSBBVA Amendment to the Final Terms
29th Dec 20217:00 amRNSBBVA GBP Final Terms
17th Dec 202110:48 amRNS2021.12.17 Share Buyback Follow up Reporting
17th Dec 20217:00 amRNSS&P's Upgrades BBVA's ratings
10th Dec 202110:18 amRNSBBVA_ Shares Buyback_Follow up Reporting
1st Dec 202110:19 amRNSBBVA_ Shares Buyback_Follow up Reporting
26th Nov 202111:24 amRNSShares Buyback Follow up Reporting
19th Nov 20214:51 pmRNSBuyback Execution
18th Nov 202112:35 pmRNSBBVA_Investor_Day_Presentations
18th Nov 202112:28 pmRNSNew shareholder's distribution policy
18th Nov 20217:00 amRNSBBVA disclosure CMB application
16th Nov 20212:15 pmRNSInvestor Day Announcement
15th Nov 20217:20 amRNSAnalysts Call _ BBVA's Voluntary Takeover Bid
15th Nov 20217:03 amRNSVoluntary Takeover Bid for Türkiye Garanti Bankasi
29th Oct 20217:00 amRNSAuthorization Share Buyback
29th Oct 20217:00 amRNS3Q21 Results Report
29th Oct 20217:00 amRNS3Q21 Results Presentation
29th Oct 20217:00 amRNS3Q21 Results Press Release
19th Oct 202110:12 amRNS3Q21 Results Presentation Announcement
30th Sep 20217:47 amRNSDividend October 2021
30th Jul 20215:48 pmRNS2020 EU-wide Stress Test
30th Jul 20217:00 amRNS2Q21 Results Report
30th Jul 20217:00 amRNS2Q21 Results Presentation
30th Jul 20217:00 amRNS2Q21 Results Press Release
29th Jul 20216:18 pmRNSChanges in the Organizational Structure
21st Jul 202111:23 amRNS2Q21 Results Presentation Announcement
13th Jul 20215:21 pmRNSMoody's upgrades BBVA's Subordinated debt
1st Jul 20218:28 amRNSHR Selection of statutory auditor BBVA
9th Jun 20217:00 amRNSHR Agreement on the collective layoff
1st Jun 20212:47 pmRNSClosing BBVA USA sale
1st Jun 20217:00 amRNS2021 MREL Requirement
30th Apr 20217:18 amRNS1Q21 Results Presentation
30th Apr 20217:16 amRNS1Q21 Results Press Release
30th Apr 20217:14 amRNS1Q21 Results Report
23rd Apr 202110:29 amRNS1Q21 Results Presentation Announcement
20th Apr 20213:36 pmRNSPost-Stabilisation Notice - BBVA
20th Apr 20212:21 pmRNSResolutions SGM 2021
17th Mar 20217:00 amRNSPre-Stabilisation Notice - BBVA
16th Mar 20217:36 amRNS2021 AGM Proposed Resolutions
16th Mar 20217:00 amRNSCash payment against share premium acc. calendar
15th Mar 20216:06 pmRNS2021 Annual General Meeting Call
12th Mar 20215:01 pmRNSBasel Accord Pillar III 2020
3rd Mar 20215:07 pmRNSEarly redemption of preferred securities
29th Jan 20217:00 amRNS4Q20 Quarterly Report
29th Jan 20217:00 amRNS4Q20 Results Press Release
29th Jan 20217:00 amRNS4Q20 Results Report
29th Jan 20217:00 amRNSShareholders' Remuneration
25th Jan 20217:00 amRNS2021 BBVA has completed the sale of BBVA Paraguay

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.